Molecular epidemiology and genomic dynamics of Pseudomonas aeruginosa isolates causing relapse infections

Cong Shen1,2, Jinxiang Zeng1,2, Dexiang Zheng1,2

  • 1The Second Clinical Medical College, Guangzhou University of Chinese Medicine , Guangzhou, China.

Microbiology Spectrum
|September 28, 2023
PubMed
Abstract

Insights

Relapse Pseudomonas aeruginosa infections are common, particularly carbapenem-resistant strains. Whole-genome sequencing reveals rapid genomic evolution and identifies a potential diagnostic and therapeutic target in the fptA gene.

Area of Science:

  • Infectious Diseases
  • Genomics
  • Microbiology

Background:

  • Pseudomonas aeruginosa (P. aeruginosa) is a major cause of chronic infections, especially in cystic fibrosis patients.
  • Relapse P. aeruginosa infections are clinically significant due to increased antimicrobial resistance and treatment challenges.
  • Understanding relapse patterns in China is crucial, as data remains limited.

Purpose of the Study:

  • To investigate the incidence and genomic characteristics of relapse P. aeruginosa infections in China.
  • To identify potential targets for improved diagnosis and treatment of recurrent P. aeruginosa infections.
  • To assess the role of whole-genome sequencing in understanding the evolution of relapse infections.

Main Methods:

  • A 3-year retrospective study (2019-2022) analyzing 442 P. aeruginosa isolates from 196 patients.
  • Clinical records screening and whole-genome sequencing (WGS) were employed to identify relapse infections.
  • Phylogenetic analysis and comparative genomics were used to study isolate evolution.

Main Results:

  • A relapse incidence of 31.6% was observed, with significantly higher rates in carbapenem-resistant P. aeruginosa infections (51.4%) compared to susceptible ones (20.2%).
  • Relapse isolates exhibited diverse sequence types, indicating no specific lineages caused recurrent infections.
  • Genomic analysis revealed rapid adaptation, including antimicrobial resistance changes, gene flux, and convergent mutations in the fptA virulence gene.

Conclusions:

  • Relapse P. aeruginosa infections are frequent and driven by rapid genomic evolution rather than specific lineages.
  • A convergent mutation in the fptA gene presents a promising target for diagnosing and treating relapse infections.
  • Integrated use of WGS and clinical data enhances diagnostics for relapsed P. aeruginosa infections, necessitating continued genomic surveillance.